Changing Comorbidity Clusters in Patients With Congenital Heart Disease Across the Lifespan
4 affiliations
- 1McGill Adult Unit for Congenital Heart Disease Excellence Montreal Québec Canada
- 2Department of Mathematics and Statistics McGill University Montreal Québec Canada
- 3Department of Epidemiology, Biostatistics, and Occupational Health McGill University Montreal Québec Canada
- 4School of Computer Science McGill University Montreal Québec Canada
Abstract
Background: Benefiting from advances in medical care, patients with congenital heart disease (CHD) now survive to adulthood but face elevated risks of cardiac and noncardiac complications. Understanding how comorbidity evolves across the lifespan is the cornerstone to improving long‐term outcomes. We hypothesized that comorbidity occurs in clusters that change over time in patients with CHD.
Methods: Using the Quebec CHD database with 35 years of follow‐up (1983–2017), we designed a longitudinal cohort study evaluating 38 International Classification of Diseases, Ninth Revision/Tenth Revision (ICD‐9/10) coded comorbidities. Observed sequences of comorbidities were mapped using median ages of onset. Associations between disease pairs were quantified using hazard ratios from Cox proportional hazard models adjusting for age, sex, genetic syndrome, competing risks of death, and time‐varying predictor diseases.
Results: The cohort comprised 9764 individuals with severe CHD and 127 728 with nonsevere CHD. Patients with severe CHD demonstrated higher cumulative probabilities of developing comorbidities than those with nonsevere CHD from birth to older adulthood. By age 40 years, cumulative probabilities for developing cardiac, vascular, endocrine/metabolic, digestive, infectious, renal, and neurological disease were ≥2‐fold higher in severe versus nonsevere CHD. Median ages of onset for most comorbidities occurred below age 40 in severe CHD, 2 to 3 decades earlier than patients with nonsevere CHD where peak comorbidity onsets occurred between their 60s and 80s. Disease progression in severe CHD began with childhood cardiovascular diseases, progressing to early‐adulthood metabolic, hepatic, renal diseases, and later heart failure and dementia.
Conclusions: Distinct multimorbidity clusters were observed by CHD severity, with earlier clustering in severe CHD, highlighting the need for early risk characterization and preventive strategies.
Related
- Thromboprophylaxis in congenital and acquired heart disease across the lifespan. A French consensus position statement: Part 2 – from adolescence to adulthood
- Comorbidity and hospital procedures in pregnancies with congenital anomalies: population-based study
- Association of the Charlson Comorbidity Index and Age-Adjusted Charlson Comorbidity Index with Clinical Course and Mortality in Patients with Idiopathic Pulmonary Fibrosis
- Real-world evidence of physical comorbidity patterns and all-cause mortality in patients with mental disorders.
- H2FPEF Score and Charlson Comorbidity Index as Independent Predictors of Cardiovascular Outcomes in Elderly Patients Undergoing Geriatric Rehabilitation
BibTeX
@article{li2026changing,
title = {{Changing Comorbidity Clusters in Patients With Congenital Heart Disease Across the Lifespan}},
author = {Chao Li and Harry Moroz and Solomon Bendayan and Maya D'Angelo and Aihua Liu and Liming Guo and Judith Therrien and Archer Yi Yang and Robyn Tamblyn and James Brophy and Yue Li and Ariane Marelli},
journal = {Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease},
year = {2026},
month = sep,
doi = {10.1161/jaha.126.048813},
url = {https://doi.org/10.1161/jaha.126.048813},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Changing Comorbidity Clusters in Patients With Congenital Heart Disease Across the Lifespan
AU - Chao Li
AU - Harry Moroz
AU - Solomon Bendayan
AU - Maya D'Angelo
AU - Aihua Liu
AU - Liming Guo
AU - Judith Therrien
AU - Archer Yi Yang
AU - Robyn Tamblyn
AU - James Brophy
AU - Yue Li
AU - Ariane Marelli
PY - 2026
DA - 2026/09/29
JO - Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
DO - 10.1161/jaha.126.048813
UR - https://doi.org/10.1161/jaha.126.048813
AB - Background: Benefiting from advances in medical care, patients with congenital heart disease (CHD) now survive to adulthood but face elevated risks of cardiac and noncardiac complications. Understanding how comorbidity evolves across the lifespan is the cornerstone to improving long‐term outcomes. We hypothesized that comorbidity occurs in clusters that change over time in patients with CHD. Methods: Using the Quebec CHD database with 35 years of follow‐up (1983–2017), we designed a longitudinal cohort study evaluating 38 International Classification of Diseases, Ninth Revision/Tenth Revision (ICD‐9/10) coded comorbidities. Observed sequences of comorbidities were mapped using median ages of onset. Associations between disease pairs were quantified using hazard ratios from Cox proportional hazard models adjusting for age, sex, genetic syndrome, competing risks of death, and time‐varying predictor diseases. Results: The cohort comprised 9764 individuals with severe CHD and 127 728 with nonsevere CHD. Patients with severe CHD demonstrated higher cumulative probabilities of developing comorbidities than those with nonsevere CHD from birth to older adulthood. By age 40 years, cumulative probabilities for developing cardiac, vascular, endocrine/metabolic, digestive, infectious, renal, and neurological disease were ≥2‐fold higher in severe versus nonsevere CHD. Median ages of onset for most comorbidities occurred below age 40 in severe CHD, 2 to 3 decades earlier than patients with nonsevere CHD where peak comorbidity onsets occurred between their 60s and 80s. Disease progression in severe CHD began with childhood cardiovascular diseases, progressing to early‐adulthood metabolic, hepatic, renal diseases, and later heart failure and dementia. Conclusions: Distinct multimorbidity clusters were observed by CHD severity, with earlier clustering in severe CHD, highlighting the need for early risk characterization and preventive strategies.
SN - 2047-9980
ER -